AU737680C - Novel compounds having antiviral activity - Google Patents

Novel compounds having antiviral activity

Info

Publication number
AU737680C
AU737680C AU27895/97A AU2789597A AU737680C AU 737680 C AU737680 C AU 737680C AU 27895/97 A AU27895/97 A AU 27895/97A AU 2789597 A AU2789597 A AU 2789597A AU 737680 C AU737680 C AU 737680C
Authority
AU
Australia
Prior art keywords
novel compounds
antiviral activity
positions
hydroxyl groups
low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU27895/97A
Other languages
English (en)
Other versions
AU2789597A (en
AU737680B2 (en
Inventor
Shuji Fujita
Masaaki Numata
Shigeki Nunomura
Mamoru Sugimoto
Kazuo Suzuki
Masaki Terada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissin Foods Holdings Co Ltd
Original Assignee
Nissin Food Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissin Food Products Co Ltd filed Critical Nissin Food Products Co Ltd
Publication of AU2789597A publication Critical patent/AU2789597A/en
Application granted granted Critical
Publication of AU737680B2 publication Critical patent/AU737680B2/en
Publication of AU737680C publication Critical patent/AU737680C/en
Assigned to NISSIN FOODS HOLDINGS CO., LTD. reassignment NISSIN FOODS HOLDINGS CO., LTD. Request to Amend Deed and Register Assignors: NISSIN FOOD PRODUCTS CO., LTD.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU27895/97A 1996-05-16 1997-05-16 Novel compounds having antiviral activity Ceased AU737680C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8-122025 1996-05-16
JP12202596 1996-05-16
PCT/JP1997/001654 WO1997043296A1 (en) 1996-05-16 1997-05-16 Novel compounds having antiviral activity

Publications (3)

Publication Number Publication Date
AU2789597A AU2789597A (en) 1997-12-05
AU737680B2 AU737680B2 (en) 2001-08-30
AU737680C true AU737680C (en) 2002-05-02

Family

ID=14825732

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27895/97A Ceased AU737680C (en) 1996-05-16 1997-05-16 Novel compounds having antiviral activity

Country Status (8)

Country Link
US (3) US6337390B1 (OSRAM)
EP (1) EP0957107B1 (OSRAM)
JP (1) JP4099234B2 (OSRAM)
AT (1) ATE271560T1 (OSRAM)
AU (1) AU737680C (OSRAM)
CA (1) CA2255070C (OSRAM)
DE (1) DE69729958T2 (OSRAM)
WO (1) WO1997043296A1 (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997043296A1 (en) * 1996-05-16 1997-11-20 Nissin Food Products Co., Ltd. Novel compounds having antiviral activity
WO1999043689A1 (fr) * 1998-02-27 1999-09-02 Meiji Milk Products Co., Ltd. Nouveaux derives de kdn et medicaments les contenant sous forme de principes actifs
EP1144420B1 (en) 1999-01-15 2003-12-10 Board Of Trustees Of The University Of Illinois Sulfated phosphatidylinositols, their preparation and use
WO2003049672A2 (en) * 2001-10-30 2003-06-19 Microbiotix, Inc. Methods and compositions for treating flavivirus-mediated disease
JP2008074720A (ja) * 2006-09-19 2008-04-03 Noguchi Inst Ｇｍ３糖鎖プローブ
CA2685127C (en) 2007-04-23 2019-01-08 Alnylam Pharmaceuticals, Inc. Glycoconjugates of rna interference agents
AU2014277867B2 (en) * 2007-12-04 2016-11-03 Arbutus Biopharma Corporation Targeting lipids
CA2708171C (en) 2007-12-04 2018-02-27 Alnylam Pharmaceuticals, Inc. Folate conjugates
CN102006890A (zh) 2007-12-04 2011-04-06 阿尔尼拉姆医药品有限公司 靶向脂质
EP3604533A1 (en) 2008-04-11 2020-02-05 Arbutus Biopharma Corporation Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
JP5327839B2 (ja) * 2008-06-09 2013-10-30 国立大学法人埼玉大学 シアル酸誘導体の製造方法とインフルエンザウィルス阻害剤としての利用
BR112012000381A2 (pt) 2009-07-07 2016-03-29 Adenovir Pharma Ab novos compostos antivirais úteis para o tratamento ou prevenção de queratoconjuntivite epidêmica
SG11201703638XA (en) 2014-11-10 2017-06-29 Alnylam Pharmaceuticals Inc Hepatitis b virus (hbv) irna compositions and methods of use thereof
WO2017027980A1 (en) * 2015-08-19 2017-02-23 National Research Council Canada Treatment and prevention of neisseria gonorrhoeae infection using cmp-activated nonulosonate analog compounds
US11324820B2 (en) 2017-04-18 2022-05-10 Alnylam Pharmaceuticals, Inc. Methods for the treatment of subjects having a hepatitis b virus (HBV) infection
MA70658B1 (fr) 2018-08-13 2026-04-30 Alnylam Pharmaceuticals, Inc. Compositions d'agent d'arndb du virus de l'hépatite b (vhb) et leurs méthodes d'utilisation
AU2022365434A1 (en) * 2021-10-14 2024-05-02 Owlstone Medical Limited Method for the synthesis of evoc probes

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0317020A (ja) * 1989-06-14 1991-01-25 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
EP0587374A2 (en) * 1992-09-02 1994-03-16 Virostat (Na) Nv Sulfated sterol glycosides and their use against viral infections.
EP0671407A2 (en) * 1994-03-04 1995-09-13 Bristol-Myers Squibb Company Sulfated alpha-glycolipid derivatives as cell adhesion inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164798A (ja) 1983-03-09 1984-09-17 Rikagaku Kenkyusho シアル酸含有糖脂質誘導体
JPH064671B2 (ja) 1985-04-02 1994-01-19 メクト株式会社 シアル酸誘導体及びその製造方法
JPS62212335A (ja) 1986-03-14 1987-09-18 Mitsui Toatsu Chem Inc ２−アリ−ル−２−メチルプロピルエ−テル誘導体およびそれを有効成分として含有する殺虫剤
JPS6345223A (ja) 1986-04-04 1988-02-26 Ueno Seiyaku Oyo Kenkyusho:Kk ひと免疫不全ウイルス性疾患処置剤
JPS63264493A (ja) 1986-12-29 1988-11-01 Mect Corp 活性カルボニル基を持つシアル酸誘導体
JPS6452794A (en) 1987-05-29 1989-02-28 Kanto Ishi Pharma Co Ltd Sialic acid-containing thioglycerolipid derivative and production thereof
JPH01125394A (ja) 1987-11-10 1989-05-17 Mect Corp シアロシルグリセロリピッド類及びその製造方法
JPH02304025A (ja) 1989-05-18 1990-12-17 Tanabe Seiyaku Co Ltd 抗レトロウィルス薬
JPH03246297A (ja) 1990-02-22 1991-11-01 Nippon Koutai Kenkyusho:Kk ガングリオシド誘導体及びこれを含有する抗ｈｉｖ剤
JPH04136001A (ja) 1990-09-27 1992-05-11 Tanabe Seiyaku Co Ltd β―シクロデキストリン・スルホンアミド誘導体のポリ硫酸エステル及びその製法
US5344417A (en) 1992-09-11 1994-09-06 Becton, Dickinson And Company Universal fitting for inoculation receptacles
JPH06256373A (ja) 1993-01-11 1994-09-13 Dainippon Ink & Chem Inc 硫酸化オリゴ糖配糖体アシル化物およびこれを有効成分とする抗ウイルス剤
JP3062906B2 (ja) * 1993-01-29 2000-07-12 丸金醤油株式会社 Ｎ−アセチルノイラミン酸ホモポリマーの硫酸エステル
JPH09183789A (ja) 1995-10-31 1997-07-15 Sanwa Kagaku Kenkyusho Co Ltd 新規な硫酸化及び燐酸化糖誘導体、その製法及び用途
WO1997043296A1 (en) * 1996-05-16 1997-11-20 Nissin Food Products Co., Ltd. Novel compounds having antiviral activity

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0317020A (ja) * 1989-06-14 1991-01-25 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
EP0587374A2 (en) * 1992-09-02 1994-03-16 Virostat (Na) Nv Sulfated sterol glycosides and their use against viral infections.
EP0671407A2 (en) * 1994-03-04 1995-09-13 Bristol-Myers Squibb Company Sulfated alpha-glycolipid derivatives as cell adhesion inhibitors

Also Published As

Publication number Publication date
US20030073664A1 (en) 2003-04-17
US6337390B1 (en) 2002-01-08
DE69729958D1 (de) 2004-08-26
US6835720B2 (en) 2004-12-28
ATE271560T1 (de) 2004-08-15
EP0957107A1 (en) 1999-11-17
EP0957107A4 (OSRAM) 1999-11-17
US20020077472A1 (en) 2002-06-20
CA2255070C (en) 2006-08-15
AU2789597A (en) 1997-12-05
WO1997043296A1 (en) 1997-11-20
CA2255070A1 (en) 1997-11-20
EP0957107B1 (en) 2004-07-21
JP4099234B2 (ja) 2008-06-11
US6541461B2 (en) 2003-04-01
DE69729958T2 (de) 2005-07-28
AU737680B2 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
AU2789597A (en) Novel compounds having antiviral activity
AU1130988A (en) Thiazolidinone derivatives, their preparation and their use
AU1089997A (en) Hyperabas: biologically active abscisic acid analogs with unsaturated carbon substituents at the 8'-methyl or 9'-methyl carbon atoms
AU578809B2 (en) Therapeutic nucleosides
IE881150L (en) Low molecular weight heparins of regular structure, their¹preparation and their biological uses
AU2206188A (en) Azithromycin and derivatives as antiprotozoal agents
AU1745988A (en) Skin treatment composition
GR3026225T3 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
CA2218872A1 (en) Preparation and use of sulfated oligosaccharides
ES2148504T3 (es) Acido hialuronico sulfatado en el que el numero de grupos sulfato por unidad repetitiva varia entre 0,5 y menos de 2.
AU5286093A (en) Novel shingoglycolipid and use thereof
AU1922688A (en) New pentasaccharides
DK15689A (da) Sukkerethere som blegestabile renseevneforstaerkere.
AU3689593A (en) Semi-synthetic glycosaminoglycans with heparin or heparan structure of alpha-L-iduronic-2-sulfate acid modified in position 2
CA2133885A1 (en) Crystalline inclusion complex of diclofenac with beta-cyclodextrin
CA2022177A1 (en) Arginine deiminase, its manufacturing method, and an anti-cancer agent containing this enzyme as an effective ingredient
CA2217710A1 (en) Cancer metastasis inhibition with n-acetylneuramic acid
AU8213487A (en) Anthracycline derivatives having cytostatic activity
AU6285390A (en) Improvements in or relating to i.c. engines
CA2047802A1 (en) Pharmaceutical compositions
EP0352826A3 (en) Use of 5-aminosalicylic acid in the treatment of dermatological disorders
ES2094623T3 (es) Procedimiento estereoselectivo para la preparacion de 2-desoxi-2,2-difluoro-d-ribofuranosil-3,5-hidroxi protegido-1-alquil y aril-sulfonatos intermedios enriquecidos en el anomero beta.
AU1254188A (en) Disaccharide derivatives
CA2041380A1 (en) Use of protein c or activated protein c for preparing a pharmaceutical preparation
KR970704456A (ko) 인터류킨 5 생성 억제제(Interleukin 5 Production Inhibitor)

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20010925

FGA Letters patent sealed or granted (standard patent)
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20020104

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20011025

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20020124